Anemia is a common feature of CKD associated with poor outcomes due to a state of erythropoietin deficiency. Anemia in CKD is typically normocytic, normochromic, and hypoproliferative.

Erythropoietin therapy has been used for approximately 20 years to correct anemia in CKD and to improve both subjective and objective outcomes. This video talks about " Management of Anemia in CKD."